Group 1: Investor Relations Activities - The company conducted a specific investor survey on January 24, 2024, at its conference room in Suzhou [2] - Participating units included major securities firms and investment companies [2] Group 2: Technology and R&D Investment - R&D expenses from 2020 to 2022 were 11.13 million, 20.46 million, and 27.10 million CNY, representing 5.88%, 6.80%, and 7.86% of revenue respectively, showing a steady increase [3] - The company has developed four core technologies for its dispensing valves, achieving breakthroughs in precision and efficiency [3][4] Group 3: Financial Performance - Total revenue for 2021, 2022, and Q3 2023 was 300.80 million, 344.86 million, and 230.41 million CNY respectively [6] - Net profit for the same periods was 66.57 million, 88.46 million, and 66.44 million CNY [6] Group 4: Application in Apple Supply Chain - The company's dispensing equipment is used in various Apple products, including iPads, MacBooks, and AirPods [7][8] - The company has established a stable cooperation with Apple, participating in the development of new products since 2017 [10][11] Group 5: Competitive Landscape - Major competitors in the Apple supply chain include Nordson, Andon, and Axis Control [10] - The company maintains a strong position due to its long-term collaboration and understanding of Apple's product development cycles [11][12] Group 6: Gross Margin Trends - The overall gross margin from 2020 to 2022 was 75.93%, 52.19%, and 59.10%, with dispensing equipment margins declining from 76.33% to 45.57% [13] - The company is implementing strategies to stabilize gross margins, including customer expansion and product innovation [14][15] Group 7: Product Validation Cycle - The product validation cycle for Apple products typically takes 4-8 months, involving multiple stages of testing and optimization [16][17][18]
卓兆点胶(873726) - 投资者关系活动记录表